PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Duke Medicine news -- Protein structure unlocks 1 mystery of multi-drug tolerance

2012-09-26
(Press-News.org) DURHAM, N.C. – The structures of key bacterial proteins have revealed one of the biochemical secrets that enables bacteria to outwit antibiotics.

In a paper published Sept. 20, 2012 in the journal Cell Reports, Duke University School of Medicine researchers and their colleagues describe the results of a series of experiments exploring multi-drug tolerance, a phenomenon that allows bacteria to become dormant and tolerate antibiotics, only to later awaken and re-infect the host. Drug tolerance is a factor in several types of stubborn, recurring infectious diseases caused by pathogenic bacteria, such E. coli, P. aeruginosa and M. tuberculosis.

"One in a million of those bacteria can become dormant for reasons we don't yet fully understand," said senior author Richard G. Brennan, Ph.D., professor and chairman of Duke's Department of Biochemistry. "And when bacteria are dormant, drugs are far, far less effective in the eradication of infection."

Multi-drug tolerance begins with a protein kinase molecule called HipA, which drives a few bacterial cells into dormancy. Eventually, these so-called "persister" cells — literally one in a million in the bacterial population — awaken to begin growing and starting the cycle of infection all over again.

"It's a very clever thing for them to do, and it's one of the underlying reasons there are so many recalcitrant infections," said Maria A. Schumacher, Ph.D., professor of biochemistry at Duke and lead author of the study.

By analyzing the structural and biochemical components at work in the HipA-mediated system, the team was able to get to the bottom of how this protein works. Schumacher, the lead structural biologist in the group, used X-ray crystallography to produce an atomic-level three-dimensional structure of HipA. This structure was pivotal to understand how this simple modification affected HipA's activity.

"This protein carries out a process called phosphorylation, which affects the activities of other molecules that control dormancy," Schumacher said. "However, too much phosphorylation by HipA is likely a very bad thing for the cell, so HipA turns itself off by an unusual self-modification, which causes the modified region to become completely disordered. In fact, this normally internal part of the protein is ejected to the outside. To the best of our knowledge, this had never been seen before in any protein of this type, and it's an incredibly unusual mechanism for how it works. From a structural biology standpoint, it's a really exciting finding."

Multi-drug tolerance is not the same as the better-known state called multi-drug resistance.

"In multi-drug resistance, bacteria evolve by a number of mechanisms to become strains that are resistant to higher and higher concentrations of antibiotics," Brennan explained. "In multi-drug tolerance, the drugs don't work because the bacteria are dormant. The persister cells simply evade most drugs until it is safe for them to re-emerge and re-infect, without having mutated."

The next steps for the researchers will be to continue their structural and biochemical studies to better understand the multiple targets of the HipA protein in the cell, and how persistence is spread throughout the cell, perhaps by multiple proteins beyond just HipA. Eventually, a highly targeted drug therapy may be in sight.

"We can see how we might be able to inhibit the protein and shut down multi-drug tolerance, at least in these types of bacteria," said Brennan.

To Schumacher and Brennan, the study is an excellent example of why basic science is important for improving clinical care and developing treatments. "This is a perfect study to show how something we're doing that is very basic can have a downstream impact upon how we think about disease and disease treatments," Brennan said. ###

Other authors include JungKi Min, and Ziqiang Guan of the Duke Department of Biochemistry; Todd M. Link, Young-Ho Ahn, Jonathan M. Kurie and Weijun Xu of the University of Texas MD Anderson Cancer Center; Erik J. Soderblom and M. Arthur Moseley of the Duke Proteomics Core Facility, Institute for Genome Sciences & Policy; Artem Evdokimov of Monsanto, St. Louis; and Kim Lewis of Northeastern University.



ELSE PRESS RELEASES FROM THIS DATE:

Taking the battle against the toxic trio beyond 'Leaves of 3, leave it be'

2012-09-26
With more than half of all adults allergic to poison ivy, oak and sumac, scientists are reporting an advance toward an inexpensive spray that could reveal the presence of the rash-causing toxic oil on the skin, clothing, garden tools, and even the family cat or dog. Using the spray, described in ACS' The Journal of Organic Chemistry would enable people to wash off the oil, or avoid further contact, in time to sidestep days of misery. Rebecca Braslau and colleagues explain that allergic reactions to oils of the toxic trio are more than a nusiance. They claim a huge human ...

Bigger wind turbines make greener electricity

2012-09-26
WASHINGTON, Sept. 26, 2012 — The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series concludes that the larger the wind turbine, the greener the electricity it produces. The study could solidify the trend toward construction of gigantic windmills. Based on a report by Marloes Caduff in ACS' journal Environmental Science & Technology, the new podcast is available without charge at iTunes and from www.acs.org/globalchallenges. In the new episode, Caduff, a graduate student, and Stefanie Hellweg, ...

Exposure to snot-nosed kids ups severity of cold infections

2012-09-26
Exposure to school-age children raises the odds that a person with lung disease who catches a cold will actually suffer symptoms like a runny nose, sore throat and cough, according to a study just published in the Journal of Clinical Virology. That finding, the result of a study that drew upon a databank of 1,000 samples of sputum and nasal secretions from people with chronic obstructive pulmonary disease or COPD, comes as a surprise, says Ann Falsey, M.D., professor of Medicine at the University of Rochester and an infectious disease expert at Rochester General Hospital. ...

Buddhist statue, discovered by Nazi expedition, is made of meteorite, new study reveals

2012-09-26
It sounds like an artifact from an Indiana Jones film; a 1,000 year-old ancient Buddhist statue which was first recovered by a Nazi expedition in 1938 has been analysed by scientists and has been found to be carved from a meteorite. The findings, published in Meteoritics and Planetary Science, reveal the priceless statue to be a rare ataxite class of meteorite. The statue, known as the Iron Man, weighs 10kg and is believed to represent a stylistic hybrid between the Buddhist and pre-Buddhist Bon culture that portrays the god Vaisravana, the Buddhist King of the North, ...

Women twice as likely to suffer infection with kidney stones and other urinary blockages

2012-09-26
DETROIT– While more men than women develop kidney stones and other obstructions in the urinary tract, women are more than twice as likely to suffer infections related to the condition, according to a new study led by Henry Ford Hospital researchers. The researchers also found significantly higher rates of complications following one of two urgent treatments for the effects of urolithiasis – or stones in the kidneys and urinary tract – but stressed that this finding is based on preliminary and more research is needed. The findings were published today in the peer-reviewed ...

Tracking koala disease: New findings from old DNA

2012-09-26
DNA extracted from the skins of koalas displayed in European and North American museums shows that a retrovirus has been a problem for the animals for much longer than was thought, according to Alfred Roca, an assistant professor of animal sciences at the University of Illinois, and Alex Greenwood of the Leibniz Institute for Zoo and Wildlife Research (LZW) in Berlin. "The process by which a retrovirus invades the host germ line appears to be quite drawn out in this case, so that the koala population has suffered the strongly pathological effects of the virus for many ...

Research breakthrough opens door to new strategy for battling HIV

2012-09-26
New research showing how the HIV virus targets "veterans" or memory T-cells could change how drugs are used to stop the virus, according to new research by George Mason University. The research will appear in the Journal of Biological Chemistry's October edition and currently is available online. "It's a big breakthrough for us," says Yuntao Wu, an author of the study and professor at the Mason-based National Center for Biodefense and Infectious Diseases. "I think this will impact the field." Helper T-cells support the body's immune system by organizing forces to ...

As population, interest in outdoor recreation grow, more pressure likely for northern forests

As population, interest in outdoor recreation grow, more pressure likely for northern forests
2012-09-26
NEWTOWN SQUARE, Penn., September 26, 2012 – Despite just modest gains in population and participation in outdoor recreation compared to the rest of the nation, there is a strong likelihood of increasing pressure on forest and other undeveloped lands in northern states as the population grows and recreation demands shift. "Outdoor Recreation in the Northern United States," a report recently published by the U.S. Forest Service's Northern Research Station as GTR NRS-100, evaluates recent population trends and forecasts within the context of other U.S. regions, demographic ...

Change in treatment regime for cryptococcal meningitis may be needed

2012-09-26
The most cost-effective treatment for cryptococcal meningitis (a serious infection of the brain membranes, usually in people with AIDS or other immune system deficiencies) is different to that currently recommended by the World Health Organization (WHO), warranting a review of policy, according to the findings of a study published in this week's PLOS Medicine. Researchers from Makerere University in Kampala, Uganda, and from the University of Minnesota in the US found that a short (7-day) course of amphotericin along with high-dose fluconazole for at least 2 weeks is ...

Large donors are forcing the World Health Organization to reform

2012-09-26
The current practice of large donors is forcing the World Health Organization and the World Bank to reflect on how to reform to remain more appealing to the wider set of stakeholders and interests at play, according to Devi Sridhar from the University of Oxford writing in this week's PLOS Medicine. Sridhar argues that since the priorities of funding bodies largely dictate what health issues and diseases are studied, a major challenge in the governance of global health research funding is agenda-setting, which in turn is a consequence of a larger phenomenon—"multi-bi ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Duke Medicine news -- Protein structure unlocks 1 mystery of multi-drug tolerance